FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

Related Articles

Insider Trading

PJT Partners Insider Sold Shares Worth $1,225,560, According to a Recent SEC Filing

Helen T Meates, Chief Financial Officer, on May 01, 2026, sold 8,000 shares in PJT Partners (PJT) for $1,225,560. Following the Form 4 filing with the SEC, Meates has control over a total of 58,466 Class A common shares of the company, with 58,466 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1626115/000119312526201703/xslF345X05/ownership.xml

$PJT
Mining & Metals

Eupraxia Pharmaceuticals Appointing Dr. Jeymi Tambiah as Chief Medical Officer With Retirement of Dr. Mark Kowalski, Current CMO

$EPRX.TO
Commodities

Scout Energy Completes $1 Billion Asset Sale in Anadarko Basin

Scout Energy on Friday announced the sale of oil and gas assets in the Western Anadarko Basin for over $1 billion, marking a significant portfolio shift.The divestiture includes a mix of upstream and midstream holdings built through multiple acquisitions, reflecting Scout's long-term strategy to scale and integrate operations, the company said.These assets produce about 250 million cubic feet equivalent per day across natural gas, natural gas liquids, and helium, spanning roughly 3 million acres in a major North American gas basin.The asset base includes three gas processing plants, over 7,200 miles of gathering pipelines, and roughly 400,000 horsepower of compression capacity."This is an important position that we built meticulously over a decade through multiple acquisitions, creating value through integration and operating improvements." John Baschab, Co-Founder and Managing Director of Scout, said.RBC Capital Markets served as exclusive financial advisor on the transaction, which advances Scout's strategy to optimize its portfolio of upstream and midstream energy assets, the company added.